Research-centric peptide and protocol reference hub
### Summary Argireline, also known as Acetyl Hexapeptide-3, is a synthetic peptide commonly utilized in cosmetic formulations for its potential anti-aging properties. It is often marketed as a topical alternative to botulinum toxin, aiming to reduce the appearance of fine lines and wrinkles.
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community ratings. Open the full chart for per-category detail; rate via the Contribute button.
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.
Studies, clinical trials, community discussions, and news.
The study evaluated the effects of Acetyl Hexapeptide-8 (AH8) on blepharospasm. The population and specific dosages were not detailed in the abstract. Outcomes related to the treatment's efficacy were assessed.
This study investigated the wrinkle reduction potential of a novel compounded skin care cream containing Argireline. The trial involved human subjects, but specific details on the sample size and dosage were not reported. The outcomes related to wrinkle reduction were assessed, but no specific numeric results were provided in the abstract.
This study evaluated the effects of an eye serum on improving the appearance of the periorbital area. The specific dose and duration of treatment were not reported in the abstract. The outcomes measured included various parameters related to the appearance of the skin around the eyes.
This study evaluated the efficacy and safety of topical Argireline in treating periorbital wrinkles. The population and specific dosage were not detailed in the abstract. The findings regarding efficacy and safety are not reported in abstract.
The study evaluated the effects of Acetyl Hexapeptide-8 on blepharospasm in a placebo-controlled, double-blind design. The specific dose and duration of treatment were not reported in the abstract. The outcomes measured included the severity of blepharospasm symptoms.
This pilot study evaluated the effects of topical Acetyl Hexapeptide-8 on the cosmetic appearance of oily skin. The study involved participants with oily skin, although specific demographic details were not provided. Not reported in abstract.
Not reported in abstract.
Not reported in abstract.
Not reported in abstract.
The study explores the effects of BAK and Argireline in a zebrafish model, but specific outcomes and their implications for human use are not detailed.
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
How-to and safety articles applicable to every peptide in the library.
No comments yet. Share research notes, citations, or observations below.
No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline
Refreshed content for Argireline